Taysha Gene Therapies, Inc. (TSHA) Form 8-K — Jun 25, 2026
$TSHAForm 8-KItems 1.01, 8.01, 9.01Filed Jun 25, 2026, 8:00 AM ET0001193125-26-282855Original filing
Taysha Gene Therapies, Inc. has priced an underwritten public offering of 32,500,001 shares of common stock and pre-funded warrants to purchase 833,333 shares at a public price of $6.00 per share. The underwriters have a 30-day option to purchase up to an additional 5,000,000 shares of common stock. The company estimates net proceeds of approximately $187.4 million, or approximately $215.6 million if the underwriters exercise their option in full.
Key figures
- Offering Price
- 6.00
- Shares Offered
- 32500001
- Greenshoe shares
- 5000000
- Warrants offered
- 833333
- Net proceeds estimated usd
- 187.4 million
- Net proceeds full option usd
- 215.6 million
Price after filing
1 day: 0.0%7 days: +7.1%30 days: -6.1%
Close on the filing date to close N calendar days later (from $6.21). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.